Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2003 May;59(1):23-8.
doi: 10.1007/s00228-003-0575-5. Epub 2003 Mar 11.

Quinine 3-hydroxylation as a biomarker reaction for the activity of CYP3A4 in man

Affiliations
Clinical Trial

Quinine 3-hydroxylation as a biomarker reaction for the activity of CYP3A4 in man

Rajaa A Mirghani et al. Eur J Clin Pharmacol. 2003 May.

Abstract

Objective: To investigate the usefulness of the 3-hydroxylation of quinine as a biomarker reaction for the activity of CYP3A4 in man and to study the interindividual variation in the metabolic ratio (MR), i.e. quinine/3-hydroxyquinine.

Methods: Data from a previous study (A) was used for determination of the MR of quinine in plasma and urine at different time points. In study B, 24 healthy Swedish subjects received 250 mg quinine hydrochloride first alone and later together with four other CYP probe drugs [losartan (CYP2C9), omeprazole (CYP2C19), debrisoquine (CYP2D6) and caffeine (CYP1A2)] administered on the same day. Plasma and urine samples were collected before quinine intake and 16 h thereafter and analysed for quinine and 3-hydroxyquinine using high-performance liquid chromatography. Plasma and/or urine were collected for the other probes at different time points. MRs of all the probes were determined and correlations to quinine MR were studied.

Results: In study A, the MR in plasma was stable over 96 h. The ratio increased from 5.8 to 12.2 (P=0.006) during co-administration with ketoconazole, whereas no significant difference (P=0.76) was observed during co-administration with fluvoxamine (from 5.8 to 6.0). In study B, there was no significant difference (P=0.36) between the mean MRs when quinine was given alone (4.7) or together with the four other drugs (4.5). There was a significant correlation between the MR of quinine and omeprazole sulphone formation (r=0.52, P<0.01), but not to the MRs of the other probes. There was a fivefold interindividual variability in the MR.

Conclusions: The MR of quinine in plasma or urine may serve as a stable measure of the activity of CYP3A4 in man. These results together with in vitro data show that quinine is also a specific CYP3A4 probe.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Clin Pharmacol Ther. 1992 Jan;51(1):18-23 - PubMed
    1. Eur J Clin Pharmacol. 1996;49(5):383-6 - PubMed
    1. Biochem Pharmacol. 1993 Mar 24;45(6):1211-4 - PubMed
    1. Arch Biochem Biophys. 1994 Jun;311(2):437-42 - PubMed
    1. J Chromatogr B Biomed Sci Appl. 2001 Apr 15;754(1):57-64 - PubMed

Publication types

MeSH terms

LinkOut - more resources